Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice
Overall, CGP of non-myeloid hematologic malignancies identified clinically significant variants in 72% of patients and resulted in a change in management in 22% of patients.
Authors
- John H. Strickler (ORCID: https://orcid.org/0000-0001-7579-1175)
- Matthew Stuart McKinney (ORCID: https://orcid.org/0000-0002-2979-4882)
- Katherine I. Zhou (ORCID: https://orcid.org/0000-0001-6442-0475)
- Bennett Adam Caughey (ORCID: https://orcid.org/0000-0002-3970-1651)
- Michael Datto (ORCID: https://orcid.org/0000-0002-9777-383X)
- Chenyu Lin (ORCID: https://orcid.org/0000-0002-4542-4232)
- Michelle Green (ORCID: https://orcid.org/0000-0002-6055-4342)
Institutions
- Duke University (US)
- LabCorp (United States) (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Hematology Reports
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3390/hematolrep16040059
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00